Clinical Trials and Research Projects  
Vet Clinical Trials
VIN.com


Vet Clinical Trials

Search


Browse by category






Powered By VIN

 

Introduction

Introduction

A listing on this page does not imply that the project has been evaluated and endorsed by either VIN or the consultants. The projects are listed here to facilitate research in animal health. If you have specific questions about these studies, please direct them to the contact person listed. Enrollment in any of these studies may close at any time.

Investigators:
If you would like to add your clinical trial or research project to this page, please complete this survey. This survey provides us with most of the information necessary to list your study, and provides “full disclosure” for VIN members, so that they can be more fully informed when considering enrolling clients and patients. You can also e-mail any questions or comments to mrishniw@vin.com.


Recent trials

Latest articles

  • Use of Canine Struvite Dissolution Diet in the Management of Infection Induced Struvite Stones in Dogs Open link in new window
    8/30/2017
    We hope to provide another effective dietary option to struvite dissolution in dogs. By feeding the test diet (brand blinded to client) and antibiotics we expect that dissolution of canine struvite bladder stones will occur within a 12-week period.
    Dr Westropp is looking for dogs with struvite uroliths.
    See the trial page for specific information on eligibility.
  • Incidence, Prevalence, and Genetics of Canine Diabetes Open link in new window
    5/15/2017
    The survey hopes to use this data to investigate the prevalence, incidence, and potentially mode of inheritance of diabetes mellitus in dogs at increased risk for the disease, as well as that of the general population and those at decreased risk.
    Dr Cai is looking for dogs with and without diabetes mellitus.
    See the trial page for specific information on eligibility.
  • Exotic Tumor Database Open link in new window
    2/21/2017
    The Exotic Tumor Database will combine cases from multiple institutions to obtain statistically significant information on treatment outcomes for non-domestic species with cancer. This information can help clinicians guide therapy as well as guide researchers to develop clinical trials.
    Drs Zehnder and Harrison are looking for any exotic animal species with a histologically diagnosed tumor.
    See the trial page for specific information on eligibility.
  • Study of the Utility of Rivaroxaban or Clopidogrel for prevention of recurrent Arterial Thromboembolism in cats (SUPERCAT) Open link in new window
    2/1/2017
    The SUPER-CAT trial compares clopidogrel to rivaroxaban for prevention of cardiogenic thromboembolism in cats that have experienced and recovered from a cardiogenic thromboembolism.
    Dr Brainard is looking for cats with aortic thromboembolism (saddle thrombus).
    See the trial page for specific information on eligibility.
  • Effects of Cyclosporine on Activated T-Cell Expression of IL-2 and IFN-gamma in Dogs (Study Closed) Open link in new window
    5/16/2016
    We hope to establish baseline (pre-treatment) levels of activated T-cell expression of IL-2 and IFN-gamma in dogs with anal furunculosis. These baseline values will help us to interpret results using the same assay from dogs with anal furunculosis that are receiving cyclosporine.
    Dr Mackin is looking for dogs with anal furunculosis.
    See the trial page for specific information on eligibility.
  • Pilot study of re-directed autologous T cell therapy for drug resistant or refractory CD20+ B cell lymphoma (Study Closded) Open link in new window
    4/12/2016
    This trial is evaluating whether T lymphocytes, genetically modified to express a chimeric antigen receptor against CD20, can be administered safely to dogs with relapsed B cell lymphoma and whether they can eliminate B cells and prolong overall survival.
    Dr Mason is looking for dogs with B-cell lymphoma have relapsed after initial remission.
    See the trial page for specific information on eligibility.